Quantcast

Invatec’s Share of the US PTA Balloon Catheter Market is Small But Growing, Showing Promise for New Acquisition Partner, Medtronic, According to Millennium Research Group

August 5, 2010

WALTHAM, Mass., Aug. 5 /PRNewswire/ — According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Invatec has traditionally held a much stronger position in the European percutaneous transluminal angioplasty (PTA) balloon catheter market compared to the US. Nonetheless, sales of Invatec’s PTA balloon catheters picked up in the US in Q1 2010, according to MRG’s Peripheral Vascular Marketrack(TM) study, coinciding with Medtronic’s announcement that they would purchase the company. Further success of the Invatec product lines in the US will be bolstered by Medtronic’s established sales and marketing efforts.

Invatec, whose purchase by Medtronic was finalized in April of this year, is known for its high-quality PTA product line for the treatment of peripheral artery disease, especially in Europe, where the company was the fourth-leading competitor in the PTA balloon catheter market in 2009. Conversely, Invatec products captured approximately 5% of the US PTA balloon catheter market in 2009, where it offered only a selection of its products. Medtronic’s acquisition of Invatec is expected to benefit both companies and has the potential for a synergistic relationship — with Medtronic broadening its peripheral vascular product line and Invatec expanding its presence in the US market.

“Invatec has traditionally maintained only a small presence in the US PTA balloon catheter market, meaning significant opportunity exists for Medtronic to expand the presence of these product lines in the US,” says Stephanie Labelle, Manager of the Cardiovascular division at MRG. “The Invatec product line will benefit from Medtronic’s existing relationships with physicians using its drug-eluting coronary stents and aortic stent grafts, therefore expanding Invatec’s penetration into US facilities. In addition, Medtronic may consider bringing additional Invatec products to the US marketplace that would further increase the company’s share of the peripheral vascular device market, including the IN.PACT ADMiRAL drug-eluting balloon, the CRiSTALLO iDEALE carotid stent, and the innovative MO.MA ULTRA embolic protection device, which are currently available in Europe, and would further increase the company’s competitiveness in the US peripheral vascular device market.”

MRG’s Peripheral Vascular Marketrack(TM) project gathers facility level procedure and product usage data on treatments for peripheral artery disease. Data is collected on a monthly basis in the US, and a quarterly basis in Europe from interventional radiology labs, interventional cardiology labs, and operating rooms throughout the US and Europe. Marketrack(TM) subscribers receive thousands of data points, including usage (units, average selling price, and revenue), procedure, competitor, and brand information.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 ext. 101
    akrohn@mrg.net

    Chris Comfort
    Decision Resources, Inc.
    781-296-2597
    ccomfort@dresources.com

SOURCE Millennium Research Group


Source: newswire



comments powered by Disqus